Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disease1 with an estimated global incidence of approximately 1 in 14,000–18,000 live births2 A phase II trial has recently been ...

In 2023, there were an estimated 44 thousand total incident cases of kidney transplants across the 7MM, with the number ...

The Global Monoclonal Antibody Therapeutics Market is valued at approximately USD 205.09 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 15.0% over the forecast ...

HONG KONG, April 18, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that ebdarokimab, an investigational monoclonal antibody developed by the company ...

Traditional monoclonal antibodies (mAbs), primarily immunoglobulin G ... – Approved in 2022, Faricimab is a humanized bispecific ... Biointron’s Fast-Track Bispecific Antibody Production: ...

We next utilized the mouse anti-mouse IL1RAP monoclonal antibody mCAN10 to block IL1RAP-mediated signaling. mCAN10 is a pure blocking antibody as it contains an LALA-PG modification in the Fc region ...

The company’s Hu14.18K322A is a humanized, anti-GD2 monoclonal antibody that latches onto the surface of neuroblastoma tumor cells. ... The company’s phase 3 candidate emactuzumab is a monoclonal ...

Human monoclonal antibodies (mAbs) stand out for their effective modulation in effector functions and lower immunogenicity compared to chimeric or humanized mAbs. Production methods involving phage ...

Antibody specificity of the selected humanized monoclonal antibodies was confirmed, and tested by the participants of the ISBT Granulocyte Immunobiology Working Party (GIWP) workshop 2020. GIFT ...

SAN DIEGO, Aug. 21, 2023 /PRNewswire/ -- GemPharmatech is proud to announce the launch of NeoMab™, our independently developed fully antibody gene humanized mouse model, after four years of ...